Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
13.91
-0.89 (-6.01%)
Apr 22, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $509.56 million as of April 22, 2026. Its market cap has increased by 1,000.23% in one year.
Market Cap
509.56M
Enterprise Value
788.89M
1-Year Change
1,000.23%
Ranking
Category
Stock Price
$13.91
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $509.56M, an increase of 1,000.22%. That is a compound annual growth rate of 41.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 542.17M | 137.13% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 535.13M |
| Verastem | 533.21M |
| Upstream Bio | 524.61M |
| ADC Therapeutics | 520.21M |
| Fulcrum Therapeutics | 516.15M |
| AgomAb Therapeutics NV | 514.17M |
| vTv Therapeutics | 501.97M |
| 4D Molecular Therapeutics | 500.30M |